Anti-helicobacter regimens
Bateson, M.C.
Lancet 347(9009): 1194
1996
ISSN/ISBN: 0140-6736 PMID: 8609800 Document Number: 463437
Document emailed within 1 workday
Related Documents
Zerbib, F. 1998: Helicobacter pylori et anti-inflammatoires non stéroïdiens Helicobacter pylori et reflux gastro-œsophagien - Helicobacter pylori and NSAID. Helicobacter pylori in GORD Hepato-Gastro (Montrouge) 5(FEV): 56-60Rathi, P.; Sawant, P.; Gopanpallikar, A. 2000: Comparison of two regimens on eradication of Helicobacter pylori Journal of the Association of Physicians of India 48(8): 852-853
Bologna, E.; Stroppiana, M.; Peyre, S.; Rizzi, R.; Sategna-Guidetti, C. 1992: Helicobacter pylori infection: comparison among four different therapeutic regimens Panminerva Medica 34(1): 13-18
Tucci, A.; Poli, L.; Gasperoni, S.; Varoli, O.; Paparo, G.F.; De Giorgio, R.; Stanghellini, V.; Corinaldesi, R. 1994: Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection Italian Journal of Gastroenterology 26(3): 107-110
Tursi, A.; Cammarota, G.; Montalto, M.; Papa, A.; Cuoco, L.; Veneto, G.M.; Cannizzaro, O.; Fedeli, G.; Gasbarrini, G. 1996: Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication Panminerva Medica 38(3): 145-149
Shimamoto, C.; Tokioka, S.; Hirata, I.; Tani, H.; Ohishi, H.; Katsu, K-ichi. 2002: Inhibition of Helicobacter pylori infection by orally administered yolk-derived anti-Helicobacter pylori antibody Hepato-Gastroenterology 49(45): 709-714
Koizumi, W.; Tanabe, S.; Imaizumi, H.; Hibi, K-ichi.; Kida, M.; Ohida, M.; Okayasu, I.; Saigenji, K. 2003: Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection Hepato-Gastroenterology 50(49): 293-296
Cui, M.; Hu, F.; Jiang, H.; Zheng, X. 2002: Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection Zhonghua Yi Xue Za Zhi 82(18): 1245-1248
Nixon, W.E.; Cargille, C.M. 1971: Binding of tracer FSH, LH, GH, and TSH by anti-FSH sera prepared by several immunization regimens Journal of Laboratory and Clinical Medicine 78(6): 949-956
Aminian, K.; Farsad, F.; Ghanbari, A.; Fakhreih, S.; Hasheminasab, S.M. 2010: A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 31(4): 303-307
Caccavo, D.; Leri, O.; Ferri, G.M.; Perinelli, P.; De Luca, D.; Afeltra, A. 1997: Anti-TNF-alpha antibodies are not associated with Helicobacter pylori induced gastritis European Review for Medical and Pharmacological Sciences 1(4): 111-113
Tsaregorodtseva, T.M.; Serova, T.I.; Gladilina, M.V.; Gubina, A.V. 2006: Contents of anti-Helicobacter pylori antibodies in digestive system diseases Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 54-58
Saltanova, S.D.; Tkach, O.S. 2003: Efficacy of anti-Helicobacter therapy in children with ulcer-like functional dyspepsia Likars'ka Sprava 8: 47-49
Xie, Y.; Zhou, N.-j.; Xiong, S.-y.; Chen, J.; Gong, Y.-f.; Lü, N.-h.; Wang, C.-w. 2007: Anti-Helicobacter pylori effect and regulation of T helper response of chitosan Zhonghua Nei Ke Za Zhi 46(3): 220-223
Zaterka, S. 2001: Anti-secretory agents modify the gastric localization of Helicobacter pylori Arquivos de Gastroenterologia 38(1): 1-2
Fradkin, A.; Yahav, Y.; Diver-Haber, A.; Weisselberg, B.; Jonas, A. 1997: The value of anti-Helicobacter pylori IgG antibodies in establishing eradication of infection in children Israel Journal of Medical Sciences 33(2): 87-92
Stringer, J.S.A.; Mwango, A.J.; Giganti, M.J.; Mulenga, L.; Levy, J.W.; Stringer, E.M.; Mulenga, P.; Saag, M.S.; Musonda, P.; Williams, F.B.; Reid, S.E.; Chi, B.H. 2012: Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study International Journal of Epidemiology 41(2): 448-459
Kirika, N.V.; Bodrug, N.I.; Butorov, S.I.; Verbitskiĭ, O.N.; Ridlovskiĭ, A.I.; Butorov, I.V.; Lagutkin, D.I.; Martyniuk, L.I. 2003: Clinical efficacy of combined anti-Helicobacter treatment of patients with duodenal ulcer Klinicheskaia Meditsina 81(1): 37-39
Goddard, A.F.; Spiller, R.C. 1997: In vitro assessment of gastric mucosal transfer of anti-Helicobacter therapeutic agents Antimicrobial Agents and ChemoTherapy 41(6): 1246-1249
Tsaregorodtseva, T.M.; Serova, T.N.; Klishina, M.v.; Trubitsina, I.E.; Sokolova, G.N.; Rogozina, V.A.; Chikunova, B.Z.; Zhivaeva, N.S.; Gubina, A.V. 2005: Diagnostic and prognostic value of anti-Helicobacter pylori antibodies at diseases of the digestive apparatus Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 18-21